Fundz
Funding, M&A and exec moves matched to your market — guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →

Jubilant Ingrevia acquires 40% stake in Zettaone

PRIVATEAug 19, 2026•about 3 hours ago

Acquiring Company

Jubilant Ingrevia Ltd

Acquired Company

Zettaone Technologies India Pvt Ltd

NoidaIndiaManufacturingBiotechnologyManufacturingElectronics

Description

Jubilant Ingrevia Ltd has entered into a binding agreement to acquire a 40% stake in Zettaone Technologies India Pvt Ltd for ₹189.2 crore. This strategic investment aims to strengthen Jubilant Ingrevia's engagement with customers in the electronics and semiconductor sector. The acquisition will leverage Zettaone's capabilities in electronics design and manufacturing.

Company Information

Company

Jubilant Ingrevia Ltd

Location

Noida, Uttar Pradesh, India

About

Jubilant Ingrevia Ltd is a specialty chemicals and contract development and manufacturing organization. The company focuses on providing comprehensive solutions in the life science sector. It aims to capitalize on its proven manufacturing capabilities and strong customer engagement. Jubilant Ingrevia operates in various segments, catering to diverse industry needs.

Don't miss Jubilant Ingrevia Ltd's next move

Get an email the moment Jubilant Ingrevia Ltd makes an acquisition, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Jubilant Ingrevia Ltd's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Zettaone Technologies India Pvt Ltd?

Zettaone Technologies India Pvt Ltd was acquired by Jubilant Ingrevia Ltd, based in Noida. The deal was reported on August 19, 2026. Jubilant Ingrevia Ltd is a specialty chemicals and contract development and manufacturing organization. The company focuses on providing comprehensive solutions in the life science sector. Jubilant Ingrevia Ltd is privately held and operates in Manufacturing.

When did Jubilant Ingrevia Ltd acquire Zettaone Technologies India Pvt Ltd?

Jubilant Ingrevia Ltd's acquisition of Zettaone Technologies India Pvt Ltd was reported on August 19, 2026. Jubilant Ingrevia Ltd has entered into a binding agreement to acquire a 40% stake in Zettaone Technologies India Pvt Ltd for ₹189.2 crore. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Zettaone Technologies India Pvt Ltd do?

Zettaone Technologies is an electronics design and manufacturing platform. The company specializes in integrated solutions within the electronics and semiconductor industry. It was co-founded by Harikrishnan, Sureshkumar, Prabu, and Arunkumar. It is privately held, operating in Manufacturing, and is based in India.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.